Montelukast Sodium Tablet
Product Images NDC 70518-4753

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Montelukast Sodium (NDC 70518-4753). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (21b0f1b6 9603 4620 8d26 016b126bb88a 01)

Chemical structure of Montelukast Sodium, illustrating its molecular components including ring systems, sulfur atom, carboxylate group, and sodium ion.*

FDA Label Image

Image (21b0f1b6 9603 4620 8d26 016b126bb88a 02)

Line graph showing mean percent change from baseline over weeks in treatment for Montelukast Sodium versus placebo. The x-axis represents weeks in treatment including a washout period, while the y-axis shows mean percent change. Montelukast Sodium demonstrates greater percent change compared to placebo throughout treatment.*

FDA Label Image

Remedy_label (Remedy Label)

Montelukast Sodium 10 mg tablet label shows a quantity of 90 tablets. The label includes NDC number 70518-4753-00 and indicates repackaging by RemedyRepack Inc., Indiana, PA. The label instructs usual dosage to be found in the insert and includes storage directions and manufacturing details from Rising Pharma, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.